Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frishman

Showing results (431-440 of 1,860) with videos related to

Pageof 186
Sort By:
American Heart Journal|December 1, 1996
Recombinant growth hormone: a new cardiovascular drug therapyM Gomberg-Maitland, W H Frishman
Journal of Neurosurgery|October 29, 2010
A report on the treatment of craniocerebral wounds in an evacuation hospitalT A WEAVER, A J FRISHMAN
Cardiology in Review|June 12, 2010
The antiplatelet effects of nitrates: is it of clinical significance in patients with cardiovascular disease?Rui-Hai Zhou, William H Frishman
Southern Medical Journal|June 10, 2010
Angiotensin receptor blockers for management of hypertensionDaniel F Catanzaro, William H Frishman
Zhurnal Evoliutsionnoi Biokhimii I Fiziologii|January 1, 1990
[The evolution of signal receptor proteins: conserved regions and the similarity to GTP-binding proteins]D I Frishman, A L Berman
The American Journal of Cardiology|November 6, 1990
Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockadeW H Frishman, E J Lazar
American Heart Journal|March 7, 1998
Thyroid hormone and cardiovascular diseaseM Gomberg-Maitland, W H Frishman
Journal of Neurophysiology|June 1, 1989
Intraretinal analysis of the threshold dark-adapted ERG of cat retinaL J Frishman, R H Steinberg
Archives of Internal Medicine|June 1, 1981
Nifedipine in hypertension. Expanding applications of a new drugW Frishman, N Klein, N Beer
Cardiology in Review|March 8, 2023
A Novel Approach to Calcium Destruction in Coronary and Peripheral Blood Vessels: Intravascular LithotripsyPeter D Lenchur, William H Frishman
Pageof 186

Showing results (431-440 of 1,860) with videos related to

Sort By:
Pageof 186
American Heart Journal|December 1, 1996
Recombinant growth hormone: a new cardiovascular drug therapyM Gomberg-Maitland, W H Frishman
Journal of Neurosurgery|October 29, 2010
A report on the treatment of craniocerebral wounds in an evacuation hospitalT A WEAVER, A J FRISHMAN
Cardiology in Review|June 12, 2010
The antiplatelet effects of nitrates: is it of clinical significance in patients with cardiovascular disease?Rui-Hai Zhou, William H Frishman
Southern Medical Journal|June 10, 2010
Angiotensin receptor blockers for management of hypertensionDaniel F Catanzaro, William H Frishman
Zhurnal Evoliutsionnoi Biokhimii I Fiziologii|January 1, 1990
[The evolution of signal receptor proteins: conserved regions and the similarity to GTP-binding proteins]D I Frishman, A L Berman
The American Journal of Cardiology|November 6, 1990
Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockadeW H Frishman, E J Lazar
American Heart Journal|March 7, 1998
Thyroid hormone and cardiovascular diseaseM Gomberg-Maitland, W H Frishman
Journal of Neurophysiology|June 1, 1989
Intraretinal analysis of the threshold dark-adapted ERG of cat retinaL J Frishman, R H Steinberg
Archives of Internal Medicine|June 1, 1981
Nifedipine in hypertension. Expanding applications of a new drugW Frishman, N Klein, N Beer
Cardiology in Review|March 8, 2023
A Novel Approach to Calcium Destruction in Coronary and Peripheral Blood Vessels: Intravascular LithotripsyPeter D Lenchur, William H Frishman
Pageof 186